EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations

Christian Schöneich iD

Biochemical Society Transactions · 27.05.2026 · 54 (5) · 523-533

DOI: 10.1042/bst20250134 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 14.05.2026. Verfasst von Christian Schöneich. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, The University of Kansas, 2093 Constant Avenue, Lawrence, KS 66047, U.S.A. Hauptthemen laut MEDLINE: Antibodies, Monoclonal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KU | Department of Pharmaceutical Chemistry, University of Kansas (Pharmaceutical Chemistry).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidation represents a key pathway for the chemical degradation of therapeutic monoclonal antibodies (mAbs), and chemical liabilities such as amino acid residue oxidation are an integral part of developability studies. Mechanistically, oxidation reactions in formulations of therapeutic mAbs are frequently not well understood, as critical information such as the nature of the oxidant(s) is frequently lacking. This brief review summarizes recent screening and developability studies of therapeutic proteins specifically focusing on oxidative liabilities and discusses these data in view of mechanistic and complementary analytical information on the oxidation of amino acid residues in specific protein sequences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalOxidation-ReductionHumansDrug DesignAmino AcidsAnimalsDrug CompoundingChemistry, Pharmaceutical

Stichwörter der Autor:innen

OxidationProteinantibodydevelopabilitypharmaceutical formulation

Substanzen

Antibodies, MonoclonalAmino Acids

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, The University of Kansas, 2093 Constant Avenue, Lawrence, KS 66047, U.S.A.

ORCID-Profile: Christian Schöneich

Förderung

  • KU | Department of Pharmaceutical Chemistry, University of Kansas (Pharmaceutical Chemistry)

Zitieren

APA

Schöneich, C. (2026). Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations. Biochemical Society Transactions, 54(5), 523-533. https://doi.org/10.1042/bst20250134

Vancouver

Schöneich C. Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations. Biochemical Society Transactions. 2026;54(5):523-533. doi:10.1042/bst20250134

BibTeX
@article{Schneich2026,
  author = {Schöneich, Christian},
  title = {Mechanistic insight into the oxidative degradation of monoclonal antibodies: relevance to developability and the design of stable pharmaceutical formulations},
  journal = {Biochemical Society Transactions},
  year = {2026},
  volume = {54},
  number = {5},
  pages = {523--533},
  doi = {10.1042/bst20250134}
}
Kostenlos starten →